Hangzhou Biotest Biotech Co Ltd Class A 688767
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥26.08
- Day Range
- ¥26.20–27.08
- 52-Week Range
- ¥22.23–36.70
- Bid/Ask
- ¥26.99 / ¥27.00
- Market Cap
- ¥2.88 Bil
- Volume/Avg
- 442,661 / 457,899
Key Statistics
- Price/Earnings (Normalized)
- 27.56
- Price/Sales
- 5.74
- Dividend Yield (Trailing)
- 2.97%
- Dividend Yield (Forward)
- 2.97%
- Total Yield
- 2.97%
Company Profile
Hangzhou Biotest Biotech Co Ltd is engaged in the research and development, manufacturing, sales and service of in vitro diagnostic reagents, raw materials and instruments.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 629
- Website
- http://www.biotests.com.cn
Comparables
Valuation
|
Metric
|
688767
|
688253
|
688068
|
|---|---|---|---|
Price/Earnings (Normalized) | 27.56 | 19.62 | — |
Price/Book Value | 1.22 | 2.70 | 0.77 |
Price/Sales | 5.74 | 8.00 | 4.95 |
Price/Cash Flow | 13.69 | 15.34 | — |
Price/Earnings
688767
688253
688068
Financial Strength
|
Metric
|
688767
|
688253
|
688068
|
|---|---|---|---|
Quick Ratio | 12.62 | 15.40 | 3.29 |
Current Ratio | 13.21 | 15.84 | 6.88 |
Interest Coverage | 723.11 | 2,238.82 | −253.76 |
Quick Ratio
688767
688253
688068
Profitability
|
Metric
|
688767
|
688253
|
688068
|
|---|---|---|---|
Return on Assets (Normalized) | 3.79% | 12.17% | −5.33% |
Return on Equity (Normalized) | 4.03% | 13.13% | −5.67% |
Return on Invested Capital (Normalized) | 1.13% | 12.68% | −6.61% |
Return on Assets
688767
688253
688068
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Zxthlxdtxj | Vxgm | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Pqntwxnx | Shdbn | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Vxfxmhzb | Whcqs | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Dxlsslmj | Hfhkpd | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Hhnbhnfmm | Gth | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Srpkrgqs | Vsyb | $28.1 Bil | |||
| Moderna Inc
MRNA
| Hllcjtbh | Zqys | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Pwysvtfr | Yss | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Hytmvfd | Gnjhqm | $13.4 Bil | |||
| Incyte Corp
INCY
| Fjgsjybq | Vdjwhs | $12.7 Bil |
United States